Dowling & Yahnke LLC Sells 576 Shares of Johnson & Johnson (NYSE:JNJ)

Adjust Comment Print

About 4.95M shares traded. It is down 39.85% since March 8, 2017 and is downtrending.

Granite Investment Partners LLC lessened its holdings in Johnson & Johnson (NYSE:JNJ) by 18.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). IHT Wealth Management LLC now owns 10,942 shares of the company's stock worth $122,000 after buying an additional 3,467 shares in the last quarter. The institutional investor held 8,555 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $1.11 billion, down from 17,105 at the end of the previous reported quarter. Quantbot Technologies Lp who had been investing in Johnson Johnson for a number of months, seems to be less bullish one the $346.20B market cap company. The stock increased 0.90% or $0.0101 during the last trading session, reaching $1.1312. BlackRock Inc. increased its position in shares of Johnson & Johnson by 2.6% during the 2nd quarter.

Johnson & Johnson (NYSE:JNJ) shares typically trade an average volume of 7757.47 and institutions hold 68.70% of the total shares. It has underperformed by 4.16% the S&P500. Four analysts have rated the stock with a sell rating, nine have assigned a hold rating, eight have given a buy rating and one has given a strong buy rating to the company. Therefore 67% are positive. Johnson & Johnson had 91 analyst reports since August 7, 2015 according to SRatingsIntel. On Tuesday, February 6 the stock rating was maintained by Wells Fargo with "Buy". Credit Suisse Group set a $154.00 target price on shares of Johnson & Johnson and gave the stock a "hold" rating in a research note on Monday, January 22nd. The firm has "Equal-Weight" rating given on Wednesday, October 18 by Morgan Stanley. The stock has "Outperform" rating by RBC Capital Markets on Wednesday, July 20. The firm has "Buy" rating given on Wednesday, October 11 by Jefferies. On Wednesday, April 20 the stock rating was maintained by Goldman Sachs with "Neutral". As per Tuesday, December 8, the company rating was initiated by Nomura. The stock has "Hold" rating by Jefferies on Tuesday, August 15. RBC Capital Markets maintained FMC Corporation (NYSE:FMC) on Tuesday, February 13 with "Buy" rating. The company was maintained on Friday, June 2 by BMO Capital Markets.

Montecito Bank & Trust, which manages about $288.71M US Long portfolio, upped its stake in Ishares Msci Emerging Mkt Etf (EEM) by 115,939 shares to 253,126 shares, valued at $11.34M in 2017Q3, according to the filing. It also reduced its holding in Core Laboratories N V Com (NYSE:CLB) by 9,890 shares in the quarter, leaving it with 110,122 shares, and cut its stake in Express Scripts Holding Co (NASDAQ:ESRX).

Since February 15, 2018, it had 0 insider buys, and 1 sale for $20.17 million activity. The firm has floated short ratio of 0.66%, hold to candle to sentiment indicator of Short Ratio, its stand at 2.28. Its the same as in 2017Q2.

TRADEMARK VIOLATION NOTICE: "Johnson & Johnson (JNJ) Receiving Somewhat Positive Media Coverage, Accern Reports" was originally reported by BBNS and is the sole property of of BBNS. Bristlecone Advisors LLC increased its stake in shares of Johnson & Johnson by 1.0% in the 2nd quarter. Port Solutions Limited Liability Corporation reported 2,300 shares stake. During the same period last year, the business earned $1.58 EPS. sell-side analysts predict that Johnson & Johnson will post 8.11 earnings per share for the current fiscal year. Pinebridge Investments LP owns 3,227 shares for 0% of their portfolio. RBC Capital Markets maintained Johnson & Johnson (NYSE:JNJ) on Wednesday, January 25 with "Outperform" rating. Bahamas-based Holowesko has invested 3.04% in Johnson & Johnson (NYSE:JNJ). Insight 2811 Inc reported 1.08% of its portfolio in Johnson & Johnson (NYSE:JNJ). Badgley Phelps And Bell Inc invested in 124,647 shares. Johnson & Johnson (JNJ) recently closed with fall of -0.89% to its 20-Day Simple Moving Average. (OTCMKTS:PFSCF) has 0.00% since March 8, 2017 and is. Eagleclaw Managment Limited Liability Co reported 10,694 shares. Corda Inv Ltd accumulated 206,671 shares or 3.48% of the stock. FMR LLC grew its holdings in Johnson & Johnson by 5.9% during the 2nd quarter.

Investors sentiment decreased to 1.19 in 2017 Q3. Its up 0.01, from 1.09 in 2017Q2.

Several large investors have recently bought and sold shares of JNJ. It also increased its holding in Vanguard Total Bond Mkt Index #584 (VBTLX) by 32,327 shares in the quarter, for a total of 471,189 shares, and has risen its stake in American New World Fund F3. Citigroup has "Hold" rating and $140.0 target. Hillsdale Invest reported 3,355 shares. Azimuth Capital Mgmt Llc reported 198,059 shares. Insiders own 0.19% of the company's stock. Tradewinds Mgmt Ltd holds 6,908 shares or 0.46% of its portfolio. Wells Fargo & Mn holds 0% or 78,683 shares in its portfolio. Addenda Capital Inc stated it has 59,252 shares or 0.54% of all its holdings. Scholtz And Co Limited Company accumulated 54,551 shares or 1.64% of the stock. The firm provides electricity to residential, commercial, and industrial consumers; system power, distributed generation, solar and wind products, backup generation, storage and distributed solar, demand response, energy efficiency, and on-site energy solutions; carbon management and specialty services; and various energy services, such as operations, maintenance, technical, development, and asset management services. Intersect Capital Limited Liability Corporation stated it has 33,840 shares or 2.5% of all its holdings. Da Davidson And Company reported 0.19% in Juno Therapeutics, Inc. Jpmorgan Chase & has invested 0.02% in NRG Energy, Inc. Ami Mngmt holds 1.78% or 11,530 shares.

Among 19 analysts covering Juno Therapeutics Inc (NASDAQ:JUNO), 2 have Buy rating, 0 Sell and 17 Hold. Therefore 80% are positive. The company reported $1.74 earnings per share for the quarter, beating analysts' consensus estimates of $1.72 by $0.02. The company has an average rating of "Hold" and an average target price of $146.26. M Kraus Communications reported 43,872 shares.